CVS Health names DeVaney
1h
Investor's Business Daily on MSNCVS Health Stock Gets RS Rating UpgradeCVS Health stock received a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73. Please watch the video ...
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...
Principal Securities Inc. grew its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 3.2% during the fourth ...
Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...
CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. The ...
CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...
Argus raised the firm’s price target on CVS Health (CVS) to $77 from $68 and keeps a Buy rating on the shares. Despite an uneven performance ...
It reported a medical loss ratio - a percentage of premiums spent on medical care - at a record high of 95.2% in October, as ...
A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results